India faces a silent cervical cancer crisis: Every 8 minutes, a woman dies, but HPV vaccine and early screening could prevent it
National Academy of Medical Sciences
(NAMS) is urging the Indian government to categorise cancer as a
notifiable disease
in order to improve its monitoring, prevention, and treatment strategies. This would allow health authorities to track cases more effectively and respond swiftly to emerging trends. NAMS has also highlighted the role of indigenous
HPV tests
and vaccines as crucial tools in the fight against cervical and
breast cancer
, with plans to incorporate them into the national health programme.
Indigenous HPV tests: A game changer for early detection
On the 65th foundation day of NAMS, officials presented a comprehensive report from the task force on cervical and breast cancer in India. Dr Neerja Bhatla, a leading expert and vice president of NAMS, discussed the current state of
cervical cancer
testing, as reported by TOI. Although HPV testing is the primary method for detecting cervical cancer, its high cost has limited its widespread use. To overcome this challenge, indigenous HPV tests have been developed. These tests are more affordable, easier to use, and require less training, making them suitable for implementation in primary healthcare centres.
According to the TOI report, Dr Bhatla noted, "Positive test results shouldn't cause alarm. They only indicate a potential risk. Cervical cancer develops gradually through a precancerous phase and remains preventable and treatable when detected early." The task force anticipates that these new tests will be incorporated into India's national programme, offering a simplified, cost-effective approach to cancer screening.
Play Video
Pause
Skip Backward
Skip Forward
Unmute
Current Time
0:00
/
Duration
-:-:-
Loaded
:
0%
0:00:00
Stream Type
LIVE
Seek to live, currently behind live
LIVE
Remaining Time
-
-:-:-
1x
Playback Rate
Chapters
Chapters
Descriptions
descriptions off
, selected
Captions
captions settings
, opens captions settings dialog
captions off
, selected
Audio Track
default
, selected
Picture-in-Picture
Fullscreen
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
Text
Color
White
Black
Red
Green
Blue
Yellow
Magenta
Cyan
Opacity
Opaque
Semi-Transparent
Text Background
Color
Black
White
Red
Green
Blue
Yellow
Magenta
Cyan
Opacity
Opaque
Semi-Transparent
Transparent
Caption Area Background
Color
Black
White
Red
Green
Blue
Yellow
Magenta
Cyan
Opacity
Transparent
Semi-Transparent
Opaque
Font Size
50%
75%
100%
125%
150%
175%
200%
300%
400%
Text Edge Style
None
Raised
Depressed
Uniform
Drop shadow
Font Family
Proportional Sans-Serif
Monospace Sans-Serif
Proportional Serif
Monospace Serif
Casual
Script
Small Caps
Reset
restore all settings to the default values
Done
Close Modal Dialog
End of dialog window.
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
The Top 25 Most Beautiful Women In The World
Car Novels
Undo
HPV Vaccination: A key to prevention
In addition to improved testing, NAMS is advocating for the inclusion of the HPV vaccine in the national immunisation programme. This vaccine is a critical tool in preventing cervical cancer, and the National Technical Advisory Group on Immunisation (NTAGI) has already recommended its inclusion. However, there are logistical challenges, particularly regarding whether a single or double dose regimen should be adopted. Experts are currently conducting trials on single-dose vaccines, with results expected in the coming years.
The HPV vaccine's potential to significantly reduce cervical cancer incidence is enormous, but logistical considerations must be addressed. The Indian government is working to ensure the capacity for nationwide implementation, which includes determining the most effective dosage and ensuring equitable distribution.
Live Events
A stark cancer reality: The need for comprehensive data
According to NAMS, comprehensive data collection is essential for effective policy formulation and cancer prevention. The task force's literature review found that
cancer screening in India
is currently insufficient, especially for cervical and breast cancers. NAMS officials stressed that all women over the age of 30 should undergo regular cancer screening, but the country's current screening rates remain low.
Cervical cancer is the second most common cancer among women in India, despite being the fourth most common globally. One woman dies from cervical cancer every eight minutes in the country, making it a significant public health concern. Similarly, breast cancer, which now accounts for 13.5% of all cancers in India, has seen a dramatic increase in incidence over the past few decades. Today, India records one breast cancer diagnosis every four minutes.
Improving infrastructure and screening for better outcomes
Prof SM Bose, a council member of NAMS, provided a detailed analysis of breast cancer care systems across India. The task force found that the country faces significant shortcomings in diagnosing and treating breast cancer. With approximately 200,000 new cases annually, the task force found that diagnostic services, particularly imaging and pathology, are inadequate. There is also a lack of access to advanced treatment options such as surgery, radiotherapy, and systemic therapies.
To address these gaps, NAMS is calling for an urgent upgrade to India's healthcare infrastructure. Strengthening diagnostic services and expanding treatment options will be crucial to improving outcomes for breast cancer patients. Furthermore, the task force advocates for a national screening programme that focuses on early detection and prevention, which is vital for reducing the cancer burden.
The 90:70:90 Target for 2030
NAMS has set an ambitious target for the next decade: to achieve a 90% vaccination rate, 70% screening rate, and 90% timely treatment for diagnosed cervical cancer cases by 2030. Reaching these targets would significantly reduce the incidence of cervical cancer in India, with the goal of bringing the rate to fewer than 4 cases per 100,000 women annually.
The need for comprehensive cancer prevention and treatment strategies in India is more urgent than ever. With innovative solutions such as indigenous HPV tests, vaccines, and improved healthcare infrastructure, there is hope for better early detection and more effective treatment. The push for cancer to be classified as a notifiable disease will further strengthen the country's ability to respond to the growing cancer crisis. By implementing these recommendations, NAMS believes that India can significantly reduce cancer mortality and ensure a healthier future for millions of women.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Fashion Value Chain
30 minutes ago
- Fashion Value Chain
Solo-Dex and Polymedicure Partner to Bring Opioid-Free Acute Pain Management to India and Major Asian Markets
Solo-Dex, Inc., a U.S.-based medical device innovator, and Polymedicure Ltd. (Polymed), Indias leading manufacturer of high-quality medical devices, today announced a strategic manufacturing and supply partnership to bring Solo-Dexs patented, opioid-free regional anesthesia solutions to hospitals across India for the first time. Under this agreement, Polymed will manufacture Solo-Dexs flagship product, the Fascile Continuous Peripheral Nerve Block system, in accordance with Solo-Dexs strict quality standards, for distribution across India and key global markets. The product is already approved for clinical use in the United States and Europe and is now set to support Indias expanding Enhanced Recovery After Surgery (ERAS) programs and the growth of outpatient surgical care. 'This is a game-changer for pain management in India,' said Steven Eror, CEO of Solo-Dex. 'Polymeds scale, precision, and strong regulatory framework make them the ideal manufacturing partner. Together, well deliver a transformative technology that goes far beyond suppressing pain-it blocks acute pain completely.' First-of-its-kind in India: Faster, Safer, Non-Opioid Pain Control Solo-Dexs patented device installs in under two minutes and enables continuous, localized pain relief without opioids. Unlike conventional methods that may require IV sedation and can result in patient delirium, Solo-Dex minimizes systemic drug exposure, and eliminates the need for oral opioids thereby improving patient safety, reducing recovery time, and decreasing demand on hospital resources. The technology is designed to seamlessly integrate with ERAS protocols, helping hospitals manage post-operative pain more efficiently. As Indias healthcare system increasingly embraces day surgery and outpatient models, Solo-Dex offers a solution that enhances patient throughput and satisfaction without compromising clinical outcomes. 'We are excited to be part of this international collaboration,' said Himanshu Baid, Managing Director of Polymed. 'This partnership not only brings cutting-edge pain management to Indian clinicians and patients, but also aligns with our commitment to making world-class healthcare more accessible.' Designed for Global Impact Manufacturing will take place in Polymeds ISO 13485-certified, FDA-auditable facilities, with initial orders for 100,000 units. In addition to serving India, the partnership aims to fulfill international demand across Asia, Africa, Latin America, and select European markets, with Solo-Dex overseeing global regulatory compliance and branding. 'Thanks to this agreement, Solo-Dex now has the scalable, cost-effective production capacity to meet global demand while maintaining the clinical precision and quality our technology requires,' said Eror. 'Were especially proud to collaborate with Polymed to address the worldwide need for safer, opioid-free surgical recovery.' The Solo-Dex and Polymed partnership is already engaging with leading hospital systems across India, with commercial availability expected to begin in Q4 2025. About Solo-Dex, Inc. Solo-Dex is a U.S.-based medical device company focused on opioid-free acute pain management. Its patented continuous peripheral nerve block systems enable anesthesiologists to deliver localized, long-lasting anesthesia for post-surgical recovery. Solo-Dex technology is approved for clinical use in the U.S. and EU. About Polymedicure Limited Polymed is one of Indias most trusted names in medical devices, with a portfolio of more than 125 FDA-approved and CE-marked products. With a global presence in over 100 countries, Polymed operates high-end manufacturing facilities and is committed to delivering innovative, high-quality healthcare solutions at scale.
Time of India
3 hours ago
- Time of India
5 herbs that boost gut health, according to a top gastroenterologist
Gut health significantly impacts digestion, energy, and mood. Dr. Saurabh Sethi recommends incorporating common herbs like turmeric, known for its anti-inflammatory properties, and ginger, which relieves nausea and aids digestion. Fennel seeds ease gas and bloating, while cumin promotes bile secretion. Cinnamon regulates blood sugar and calms gut motility, offering a natural approach to digestive wellness. One of the best ways to take care of your health is to start with your gut. From keeping your digestion smooth to adjusting your energy levels and mood for the day, gut health has a lot more significance than you assume. For instance, how would your day look if you felt bloated? Dr. Saurabh Sethi, a board-certified gastroenterologist trained at Harvard and Stanford, has emphasized the importance of gut health and also discussed some herbs that can help keep your digestive system in top shape. Take a look. Turmeric Taking care of your gut health doesn't necessarily mean spending on expensive and fancy supplements. Simple herbs that you find in your kitchen can help. For instance, turmeric. Turmeric has been used for its healing properties for ages, thanks to curcumin, its active compound known for anti-inflammatory and antioxidant effects. Dr. Sethi explains that turmeric helps reduce gut inflammation and supports bile flow, which aids in the digestion of fats. 'Add to warm milk or curries to soothe from the inside out,' he suggested. Ginger Your mum would have given you ginger shots every time you complained of indigestion. The gut doctor also agrees that ginger can help relieve nausea, whether caused by motion sickness, pregnancy, or digestive upset. It also stimulates saliva, bile, and gastric enzymes to improve overall digestion. If you are feeling bloated, ginger is the go-to medicine. 'I steep ginger in tea daily, especially after large meals,' Dr. Sethi says. You can also add them to your stir fries, soups, and smoothies. Fennel seeds Fennel seeds have long been praised for their digestive benefits. These seeds are used in Indian and Mediterranean cuisines to enhance the flavour, and also boost digestion. Dr. Sethi reveals that fennel seeds can naturally relieve gas and bloating. They contain compounds that help relax gastrointestinal muscles, making them effective against gas and bloating. 'Chew after meals or make a calming tea (your grandma was right),' he adds. Cumin Yes, the humble cumin in your kitchen is packed with health benefits, especially for the gut. It promotes bile secretion, which helps break down fats and improves nutrient absorption. Dr. Sethi reveals that cumin is also helpful in relieving the abdominal cramps linked with irritable bowel syndrome. 'Toast it into your dals or veggie stir-fries,' he suggests. Cinnamon Cinnamon has more beneficial effects than its spicy sweetness. Often used in sweet treats and non-vegetarian preparations, cinnamon is also known for its digestive benefits. Dr. Sethi stresses that it can help regulate blood sugar, which in turn supports steady energy and reduces digestive stress. It can also calm gut motility, so people who experience alternating constipation and diarrhea may find this herb more effective. You can add cinnamon to your oats, kefir, or sprinkle it in your coffee. 'Kahin Bada, Kahin Chhota': Ravi Kishan Uses Samosa Analogy To Demand Regulation Of Food Prices
Hans India
4 hours ago
- Hans India
ORSL® Expands its Hydration Portfolio, launches ORSL® ZERO Electrolyte Drink for Calorie-Conscious Consumers
ORSL®, India's #1 Electrolyte Drink today announced the expansion of its electrolyte and hydration portfolio with the launch of ORSL® ZERO, an electrolyte drink with zero added sugar and made with real mango pulp. With this launch, Kenvue with its brand ORSL® reinforces its commitment to providing a holistic science-backed portfolio of hydration solutions that help meet the evolving and varied needs of Indian consumers. Crafted for everyday wellness, ORSL® ZERO Mango Electrolyte Drink combines three vital electrolytes with real mango pulp and zero added sugar offering hydration that is both tasty and guilt free. The new ORSL® ZERO Mango Electrolyte Drink addresses a critical gap in the hydration space offering optimal hydration with zero added sugar and great taste for diverse consumers who love nutritious indulgence. The minimal amount of calories in ORSL® Zero Electrolyte Drink are from naturally occurring sugars of mango pulp. Suitable for individuals who are calorie conscious and careful about sugar intake as part of lifestyle wellness, ORSL® ZERO Electrolyte Drink Mango eliminates the choice between guilt-free hydration and taste. It provides a delicious way to stay hydrated while helping replenish essential electrolytes for optimal wellness. ORSL® ZERO Electrolyte Drink also provides an equally viable solution to individuals' following low-carb or keto diets, practicing intermittent fasting, or engaging in regular workouts. These groups are susceptible to electrolyte loss and dehydration due to restrictive diets, intense physical activity, or reduced fluid intake. For them, this solution delivers the perfect bridge between great taste and rehydration. Commenting on the launch, Prashant Shinde, Business Head – Self-Care, Kenvue India, shared, 'In the recent years, we have seen acceleration of health and wellness with consumers increasingly seeking nutritious solutions. With ORSL® ZERO Electrolyte Drink Mango, we wanted to offer a solution to discerning consumers who are seeking rehydration solutions with indulgence of the most-loved taste of mango. The electrolyte drink promises to help deliver rehydration with the indulgence of mango, with a benefit of zero-added sugar.' Nagarajan Ramasubramaniam, Senior R&D Director, Kenvue, added, 'Non-Diarrheal Dehydration is often underestimated, especially among those with lifestyle-related or chronic health conditions. It can quietly impact energy levels, cognition and recovery. ORSL® ZERO Electrolyte Drink Mango is scientifically formulated to support rehydration with its blend of fluid and electrolytes while its zero added sugar profile makes it suitable for those conscious about calorie consumption. ORSL® Zero Electrolyte Drink Mango will be available at pharmacies, self service outlets and quick commerce platforms. This launch is a reaffirmation of Kenvue's commitment to making everyday care and wellness more inclusive for millions of consumers.
